The Latest Breaking News from Pfizer

Incidence of serious sexually transmitted disease at 27-year high and demand for preferred antibiotic is straining manufacture

Explore the debunked claims made by the Florida State Surgeon General regarding COVID vaccines and the integration of contaminants into DNA in this insight...

State’s politically appointed surgeon general claims vaccines can contaminate human DNA but experts say comment has no merit

Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was still a long and idiosyncratic process. Traditionally, researchers had to tailor manufacturing processes and facilities for each vaccine candidate, and the scientific knowledge gained from one vaccine was often…

Big drugmakers plan to raise prices on more than 500 drugs this month, according to a Reuters report.

PFE is a beaten-down healthcare stock that trades at a discount to consensus price target estimates. Is Pfizer stock a good buy right now?

Should the government do more to support people with long-COVID?

Thin characterisation and a slightly preachy message hold this 90-minute film back, but its heart is in the right place

As Pfizer (PFE) navigates a post-pandemic world with a shifting focus away from COVID-related products, what should investors expect from this pharma giant? Let’s look at its financial metrics to know more….

The writer and stars of the brilliant BBC One film tell Katie Rosseinsky about delving into the origins of a drug that is so often associated with a punchline, but has irrevocably changed many people’s lives

The research firm assigns wide moats to companies it thinks have competitive advantages that will last at least 20 years.